About this trial
The primary purpose of this study is to evaluate cross-sectional associations between mold exposures identified with The Dust Test and self-reported physical health, emotional health, and medical diagnoses. In addition, associations between mold exposures and mycotoxin levels among users who have done mycotoxin lab testing will also be evaluated.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.
Disqualifiers
Dust Test users who do not provide informed consent for deidentified analysis and peer-reviewed publication of their data.
Trial population
All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Mold-specific quantitative PCR (MSQPCR) testing
Other interventionThe Dust Test is mold-specific quantitative PCR (MSQPCR) analysis that is being utilized to evaluate the associations between household mold organisms and a variety of human health outcomes.
Treatment groups
Trial outcomes
Primary outcomes
PROMIS - Global Health
Ten questions assessing physical and mental health. Higher scores indicate superior physical and mental health.
Secondary outcomes
Mold-related symptoms
A set of 41 potentially mold-related symptoms. Higher scores indicated worse symptoms.
Mycotoxin levels
Urinary mycotoxin levels will be assessed. Higher levels indicated greater mycotoxin presence.